Study of MTB-9655, an Inhibitor of ACSS2, in Patients With Advanced Solid Tumors
- First Posted Date
- 2021-08-04
- Last Posted Date
- 2021-12-17
- Lead Sponsor
- MetaboMed Inc
- Target Recruit Count
- 30
- Registration Number
- NCT04990739
- Locations
- 🇺🇸
Tennessee Oncology, Nashville, Tennessee, United States
🇮🇱Sourasky MC, Tel Aviv, Israel
🇮🇱Rambam MC, Haifa, Israel
© Copyright 2025. All Rights Reserved by MedPath